Can you provide the last earnings date for FREELINE THERAPEUTICS HOLDIN?
FREELINE THERAPEUTICS HOLDIN (FRLN) last reported earnings on 11/13/2023.
NASDAQ:FRLN • US35655L2060
Past quarterly earnings results for FREELINE THERAPEUTICS HOLDIN (FRLN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.23 | - | 92.18% | 5K | - | - | ||
| Q2 2023 | -4.16 | -3.20 | -29.89% | 13.33% | 620K | - | - | |
| Q1 2023 | -4.36 | -3.16 | -37.89% | 53.86% | - | - | ||
| Q4 2022 | -8.70 | -4.35 | -100.22% | 39.58% | - | - | ||
| Q3 2022 | -3.00 | -6.78 | 55.77% | -248.84% | - | - | ||
| Q2 2022 | -4.80 | -7.75 | 38.08% | -328.57% | - | - | ||
| Q1 2022 | -9.45 | -9.26 | -2.09% | -864.29% | - | - | ||
| Q4 2021 | -14.40 | -10.40 | -38.41% | -1,536.36% | - | - | ||
| Q3 2021 | -0.86 | -1.03 | 16.80% | -17.10% | - | - | ||
| Q2 2021 | -1.12 | -0.99 | -13.40% | 65.25% | - | - | ||
| Q1 2021 | -0.98 | -0.80 | -22.78% | 67.10% | - | - | ||
| Q4 2020 | -0.88 | -0.72 | -22.38% | - | - | - | ||
| Q3 2020 | -0.73 | - | - | - | - | |||
| Q2 2020 | -3.22 | - | - | - | - | |||
| Q1 2020 | -2.98 | - | - | - | - |
Notes
FREELINE THERAPEUTICS HOLDIN (FRLN) last reported earnings on 11/13/2023.
FREELINE THERAPEUTICS HOLDIN (FRLN) missed EPS estimates and missed revenue estimates in the most recent quarter.